Index of artpub/2016/pmc_26802160/

Chiorean, E. G
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab -paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
2016
https://ddd.uab.cat/record/185774
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Chiorean,_E._G2022-06-29 13:31 15  
[ ]2=CA19-9_decrease_at_8_weeks_as_a_predictor...2022-06-29 13:31 216  
[ ]3=20162022-06-29 13:31 5  
[ ]4=1857742022-06-29 13:31 34  
[TXT]pmc_26802160.dirinfo2024-10-02 04:57 341  
[ ]pmc_26802160.du2024-10-02 04:57 33  
[TXT]pmc_26802160.dupdirs2024-10-02 04:57 0  
[TXT]pmc_26802160.dupfiles2024-10-02 04:57 0  
[TXT]pmc_26802160.errors2024-10-02 04:57 0  
[IMG]pmc_26802160.gif2024-10-02 04:57 26K 
[IMG]pmc_26802160.ico2024-10-02 04:57 12K 
[TXT]pmc_26802160.info2024-10-02 04:57 17K 
[TXT]pmc_26802160.md52024-10-02 04:57 51  
[ ]pmc_26802160.pdf2024-10-02 04:57 200K 
[TXT]pmc_26802160.sha12024-10-02 04:57 59  
[TXT]pmc_26802160.sha2562024-10-02 04:57 83  
[TXT]pmc_26802160.stats2024-10-02 04:57 292  
[TXT]pmc_26802160.txt2024-10-02 04:57 55K